177 related articles for article (PubMed ID: 37918843)
1. Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives.
Kersting D; Mavroeidi IA; Settelmeier S; Seifert R; Schuler M; Herrmann K; Rassaf T; Rischpler C
J Nucl Med; 2023 Nov; 64(Suppl 2):29S-38S. PubMed ID: 37918843
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
[TBL] [Abstract][Full Text] [Related]
4. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
[TBL] [Abstract][Full Text] [Related]
5. Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.
Kersting D; Settelmeier S; Mavroeidi IA; Herrmann K; Seifert R; Rischpler C
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409161
[TBL] [Abstract][Full Text] [Related]
6. Nuclear medicine imaging methods of radiation-induced cardiotoxicity.
Polomski ES; Antoni ML; Jukema JW; Kroep JR; Dibbets-Schneider P; Sattler MGA; de Geus-Oei LF
Semin Nucl Med; 2022 Sep; 52(5):597-610. PubMed ID: 35246310
[TBL] [Abstract][Full Text] [Related]
7.
Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
[TBL] [Abstract][Full Text] [Related]
8. Radiopharmaceuticals used for diagnosis and therapy of NETs.
Papachristou M
Hell J Nucl Med; 2023; 26 Suppl():19-20. PubMed ID: 37658556
[TBL] [Abstract][Full Text] [Related]
9. Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM).
Totzeck M; Aide N; Bauersachs J; Bucerius J; Georgoulias P; Herrmann K; Hyafil F; Kunikowska J; Lubberink M; Nappi C; Rassaf T; Saraste A; Sciagra R; Slart RHJA; Verberne H; Rischpler C
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):792-812. PubMed ID: 36334105
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity.
de Geus-Oei LF; Mavinkurve-Groothuis AM; Bellersen L; Gotthardt M; Oyen WJ; Kapusta L; van Laarhoven HW
J Nucl Med Technol; 2013 Sep; 41(3):170-81. PubMed ID: 23929800
[TBL] [Abstract][Full Text] [Related]
12. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of cancer chemotherapy: implications for children.
Simbre VC; Duffy SA; Dadlani GH; Miller TL; Lipshultz SE
Paediatr Drugs; 2005; 7(3):187-202. PubMed ID: 15977964
[TBL] [Abstract][Full Text] [Related]
15. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship.
de Wall C; Bauersachs J; Berliner D
Clin Exp Metastasis; 2021 Aug; 38(4):361-371. PubMed ID: 34117981
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
17. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Imaging in Cardio-oncology.
Tong D; Zaha VG
J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
[TBL] [Abstract][Full Text] [Related]
19. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
[No Abstract] [Full Text] [Related]
20. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]